Lilly Says Antibody Drug Cuts COVID-19 Hospitalization, May Seek Emergency Use Nod Lilly Says Antibody Drug Cuts COVID-19 Hospitalization, May Seek Emergency Use Nod

Eli Lilly said on Wednesday interim trial data showed its experimental monoclonal antibody treatment reduced the need for hospitalization and ER visits for patients with moderate COVID-19.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news